Latest News - Biotech

Μια κοινή "μετάλλαξη" αλλάζει την αντίδραση του ανοσοποιητικού συστήματος σε μολύνσεις

News image

Μια ελληνική ερευνητική ομάδα, με επικεφαλής επιστήμονες του ΕΚΕΦΕ "Δημόκριτος", ανακάλυψε ότι ένας κοινός πολυμορφισμός στα κύτταρα του αν... More

EKT / National Documentation Center | Tuesday, 18 December 2012

Partnering for Cures – Biovista presentation

News image

Presentation- CFIDS Association of America / Biovista View the joint presentation by Biovista President Dr. Aris Persidis and CFIDS’ Scientific Director, Dr. Suzanne Vernon at ... More

Biovista | Thursday, 6 December 2012

FDA Approves COMETRIQ™ for Treatment of Progressive, Metastatic Medullary Thyroid Cancer

News image

Exelixis will host conference call at 5:00 p.m. EST / 2:00 p.m. PST today SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nov... More

Exelixis Inc. | Thursday, 6 December 2012

Biotech developments signal new breakthrough

News image

The study of proteins (which are found throughout every cell and tissue in the body) is of specific interest to scientists, as they are an... More

European Union | Thursday, 6 December 2012

Scientists identify genes and facial shape connection

News image

Researchers funded in part by the EU have discovered that five genes play a key role in determining human facial shapes. Presented in the jour... More

European Union | Saturday, 13 October 2012

Immune cells in 'love handles' could provide immunity against obesity

News image

A Marie Curie research Fellow has uncovered a potential ally in the fight against obesity, together with a team of international researchers.... More

European Union | Saturday, 13 October 2012

Preliminary Phase 1 Data for Cabozantinib in Japanese Patients Presented at ESMO 2012

News image

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Sep. 30, 2012-- Exelixis, Inc. (NASDAQ:EXEL) today reported preliminary data from an ongoing... More

Exelixis Inc. | Monday, 1 October 2012

More research needed to fight multidrug-resistant TB

News image

One third of the world's population is infected with tuberculosis (TB) and despite valiant efforts to combat it, TB continues to pose a serio... More

European Union | Monday, 1 October 2012

Exelixis Provides Update on ODAC Panel for Cabozantinib

News image

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Aug. 29, 2012-- Exelixis, Inc. (NASDAQ: EXEL) today was notified by the Food and Drug ... More

Exelixis Inc. | Tuesday, 11 September 2012

New EU project to seek better diagnosis of pneumonia

News image

EU-funded researchers are about to embark on a new European project that hopes to deliver a cost-effective tool for the speedy diagnosis of i... More

European Union | Tuesday, 11 September 2012

Exelixis Announces Pricing of Concurrent Offerings of 30 Million Shares of Common Stock

News image

Exelixis Announces Pricing of Concurrent Offerings of 30 Million Shares of Common Stock and $250 Million Principal Amount of Convertible Senior Subordinated Not... More

Exelixis Inc. | Thursday, 23 August 2012

Neurotez is granted US patent for the use of Leptin as a Therapy for Alzheimer’s

News image

Novel disease-modifying therapy for Alzheimer's disease BRIDGEWATER, N.J.--(BUSINESS WIRE)--Neurotez, Inc. today announced the grant of U.S. Patent number 8,227,408 by... More

Neurotez | Tuesday, 31 July 2012

FDA Grants Priority Review for Cabozantinib in Medullary Thyroid Cancer

News image

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Jul. 30, 2012-- Exelixis, Inc. (NASDAQ:EXEL) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the... More

Exelixis Inc. | Tuesday, 31 July 2012

ENAROMaTIC: Νέο αποτελεσματικό εντομοαπωθητικό κατά της ελονοσίας

News image

Ένα καινοτόμο, υψηλής αποτελεσματικότητας και περιβαλλοντικά ασφαλές εντομοαπωθητικό για την αντιμετώπιση του κουνουπιού-φορέα της ελονοσίας Anophele... More

EKT / National Documentation Center | Monday, 23 July 2012

More in: BIOTECH

White Tower Venture PartnersWhite Tower Media
fortunaclick.com - we make egaming
ΕΣΠΑ Events & Competitions
Business Directory Register & Publish your News
WTMNews Services Get Our Newsletter
Join our LinkedIn Group Subscribe to our RSS Feeds
Facebook Group Twitter

WTMNews Support